Reconstitution volume is a dose-delivery decision, not a pharmacological one. Ipamorelin is soluble in aqueous bacteriostatic water across the practical concentration range (1–10 mg/mL); the volume you select sets how many insulin-syringe units one administration will occupy. Pick the volume that maps cleanly onto the dose you plan to inject, not a default someone copied on a forum.
The arithmetic
A U-100 insulin syringe delivers 1 unit per 0.01 mL of fluid. For 10 mg (10,000 mcg) of lyophilised peptide reconstituted in X mL of bacteriostatic water:
dose per unit (mcg) = 10,000 / (X × 100)
= 100 / XCommon reconstitution volumes for a 10 mg Ipamorelin vial
| Bac water volume | Concentration | mcg per unit | 200 mcg dose | 300 mcg dose |
|---|---|---|---|---|
| 1 mL | 10 mg/mL | 100 mcg | 2 units | 3 units |
| 2 mL | 5 mg/mL | 50 mcg | 4 units | 6 units |
| 3 mL | 3.3 mg/mL | 33 mcg | 6 units | 9 units |
| 5 mL | 2 mg/mL | 20 mcg | 10 units | 15 units |
2 mL is the standard default for a 10 mg vial — round-number dose arithmetic (200 mcg = 4 units, 300 mcg = 6 units), adequate solubility, stability window matching typical 4–5 week use cadence.
Concentration effects on stability
Higher-concentration reconstitutions (5–10 mg/mL, e.g. 1 mL into a 10 mg vial) are marginally more stable than dilute reconstitutions because bulk peptide concentration reduces adsorptive loss to the vial wall and the proportion of peptide molecules exposed to oxygen/water interfaces. The effect is small within the practical range — 2 mL versus 1 mL produces no clinically relevant difference in a 4-week use window.
Very dilute reconstitutions (>5 mL for 10 mg) extend the usable period purely by volume but do not improve bioactivity. They also increase the delivered injection volume, which with ipamorelin is not a concern (SubQ handles 0.15 mL comfortably) but with other peptides may matter.
Published research dosing — reference for the math
Ghrelin-receptor agonist protocols used in growth-hormone secretagogue research: 100–300 mcg SubQ, 2–3 times daily. At 2 mL reconstitution that maps to 2–6 units per injection — within the accurate-dosing range of a standard U-100 insulin syringe (small-volume syringes lose accuracy below 2 units and above 90 units).
Practical use-through math
A 10 mg vial reconstituted in 2 mL, dosed at 300 mcg/day: vial lasts ~33 days. At 600 mcg/day (split across 3 injections): ~16 days. Both windows fit comfortably inside the 4–6 week bac-water stability ceiling — the vial is consumed before stability becomes the limiting factor.
If your dose cadence will not exhaust the vial in the stability window, aliquot into sterile insulin syringes and freeze the fraction not in immediate use. See the shelf-life FAQ for the freeze-thaw protocol.